Lexicon Pharma (LXRX) Tops Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.23 -0.45%
Revenue Growth %: -78.9%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
CULP, KFY, NNOX, More
Revenue Growth %: -78.9%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
CULP, KFY, NNOX, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $15.86 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
- Loop Capital Starts Dave Inc (DAVE) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
